Dynamic balancing: DEPTOR tips the scales

Area of Science:

• Cellular Biology
• Molecular Oncology
• Signal Transduction

Background:

• The mammalian target of rapamycin (mTOR) is a critical regulator of cellular processes.
• Dysregulation of mTOR signaling is implicated in various diseases, particularly cancers.
• Understanding mTOR's regulatory network is crucial for therapeutic development.

Purpose of the Study:

• To identify novel binding partners and regulators of mTOR.
• To investigate the functional impact of a newly identified mTOR regulator on downstream signaling.
• To explore the role of this regulator in cancer, specifically multiple myeloma.

Main Methods:

• Affinity purification coupled with mass spectrometry to identify mTOR-interacting proteins.
• Western blotting and immunoprecipitation assays to confirm protein interactions.
• Cell-based assays to assess signaling pathway modulation.

Main Results:

• A novel protein partner and regulator of mTOR was identified.
• This new regulator was shown to influence the balance of signaling pathways downstream of mTOR.
• The identified regulator plays a role in the pathogenesis of multiple myeloma.

Conclusions:

• The discovery of a new mTOR regulator expands our understanding of cellular signaling networks.
• This finding provides a potential new therapeutic target for mTOR-dysregulated cancers, including multiple myeloma.